September 28, 2010 – A new multinational trial will examine the effectiveness of embolic protection mesh stents in STEMI (ST-elelvated myocardial infarction) patients. The MASTER trial will compare the MGuard coronary stent, made by InspireMD, with standard care. The MGuard stent is covered in a polymer mesh to prevent emboli from escaping when the stent is expanded.

September 28, 2010 - Software downloaded during a routine office visit cuts the risk of inappropriate shocks by 50 percent for patients with implantable cardioverter defibrillators (ICD), according to research reported in Circulation: Journal of the American Heart Association.

September 28, 2010 – A fully automatic, all-in-one ultrasound cleansing and disinfection system, the Mides Transesophageal (TEE)-Care, offers ease-of-use and safe handling. It was recently introduced in Europe.

September 27, 2010 – A post-market study investigating a new treatment for peripheral artery disease of the superficial femoral artery (SFA) has completed enrollment. The VIPER study, which is looking at the performance of the Gore Viabahn endoprosthesis with a heparin bioactive surface, enrolled 120 patients.

September 27, 2010 – A premarket approval (PMA) application has been submitted for the Formula balloon-expandable stent to help treat patients suffering from renal artery stenosis. Cook Medical’s submission to the U.S. Food and Drug Administration (FDA) included data from the REFORM trial.

September 24, 2010 – Drug-eluting stents are beneficial in treating symptomatic peripheral artery disease (PAD) in the femoropopliteal artery. Data from the ZILVER PTX trial demonstrate that paclitaxel-eluting stents had significantly better 12-month patency rates compared to traditional angioplasty with bare-metal stents for lesions in the femoropopliteal artery (above the knee).